a) Somatostatin b) Glucagon c) Ghrelin d) Cortisol Answer: b) Glucagon Typical onset of gastric emptying delay is: a) Within minutes b) Within hours c) After weeks d) No effect Answer: b) Within hours Semaglutide injection frequency is: a) Daily b) Weekly c) Monthly d) As-needed Answer: b) Weekly A rare but serious adverse effect to monitor is: a) Hypoglycemia b) Pancreatitis c) Hyperthyroidism d) Nephrolithiasis Answer: b) Pancreatitis It is contraindicated in patients with: a) Type 1 diabetes b) Medullary thyroid carcinoma c) Obesity d) Hypertension Answer: b) Medullary thyroid carcinoma Compared to exenatide, semaglutide yields: a) Less weight loss b) More weight loss c) Higher injection frequency d) Less HbAc reduction Answer: b) More weight loss Half-life of semaglutide is approximately: a) 24 hours b) 3 days c) 7 days d) 15 days Answer: c) 7 days Excretion involves: a) High renal elimination b) Only feces c) Metabolism and minimal excretion d) Biliary excretion Answer: c) Metabolism and minimal excretion An added cardiovascular benefit was shown in: a) SUSTAIN trials b) DPP4 studies c) RAAS inhibitor trials d) REM sleep studies Answer: a) SUSTAIN trials Weight loss percentage ranges from: a) 15% b) 510% c) 1017% d) 2025% Answer: c) 1017% A significant GI side effect is: a) Increased appetite b) Nausea c) Insomnia d) Hypertension Answer: b) Nausea Semaglutide metabolism involves: a) CYP3A4 b) Proteolysis c) Renal enzymes only d) Conjugation Answer: b) Proteolysis An advantage over liraglutide is: a) Lower efficacy b) Higher weight loss c) Daily dosing d) Less frequent injection Answer: d) Less frequent injection FAQs Does semaglutide cause weight loss in non-diabetic patients

, and Philbert M
Researchers have warned that many women taking glucagon-like peptide-1 (GLP-1) receptor agonists may be unaware of the associated risks of unplanned pregnancy, or potential foetal risks linked to the medications
It was first reported by Sawyer, Hruby, Hadley and colleagues in the Proceedings of the National Academy of Sciences in 1980, and it departs from native human alpha-MSH at only two of thirteen positions: norleucine replaces the oxidation-prone methionine at position 4, and the phenylalanine at position 7 is inverted to its D-enantiomer
If you want to start a productive medication-managed approach to weight loss and need support, finding a licensed provider can help
Im 54 and feel better now than I did in my thirties." "Will be my second order!" "I lost 14 pounds and I am getting closer to my goal every week